# Chemical Composition, Enantioselective Profile, and Preliminary Screening of Biological Activities of the Essential Oil from Aerial Parts from Lasiocephalus ovatus Schltdl

## TL;DR

This study identifies the chemical makeup and tests the antibacterial, antioxidant, and anti-inflammatory properties of essential oil from Lasiocephalus ovatus, a plant used traditionally for kidney ailments.

## Contribution

This is the first study to experimentally evaluate the essential oil's antibacterial, antioxidant, and anti-inflammatory activities and its enantioselective profile.

## Key findings

- The essential oil showed antibacterial activity against Staphylococcus aureus with a MIC of 250 µg/mL.
- The oil exhibited moderate antioxidant and anti-inflammatory effects, attributed to oxygenated sesquiterpenes like spathulenol and viridiflorol.
- Enantioselective analysis revealed enantiomerically pure compounds and a scalemic mixture of germacrene D.

## Abstract

Traditionally, Lasiocephalus ovatus Schltdl. (Asteraceae) has been used as an aromatic medicinal plant, particularly in the treatment of kidney-related ailments. However, scientific evidence validating its chemical composition and bioactivity remains limited. According to our literature search, there are no previous studies on the in vitro antibacterial, antioxidant, or anti-inflammatory activities of the essential oil from the aerial parts of Lasiocephalus ovatus; therefore, this study provides the first experimental evidence of these biological activities for this species. An essential oil (EO) was steam-distilled from the aerial parts of L. ovatus, grown at 4410 m above sea level in the paramos of Chimborazo Province (Ecuador), and subsequently analyzed. The distillation yield was 0.21% (w/w) based on dry plant material. Gas chromatography was employed for qualitative (GC-MS) and quantitative (GC-FID) analyses, using two different capillary columns, coated with 5% phenyl methyl polysiloxane (non-polar) and polyethylene glycol (polar) stationary phases. Dual stationary phases were required to provide complementary selectivity, which reinforced the identification and quantification of compounds. The major components of the EO were silphinene (3.4–3.5%), δ-selinene (3.6–3.1%), β-cyclogermacrene (18.7–18.1%), kessane (4.5–4.2%), spathulenol (13.3–13.3%), viridiflorol (3.1–3.0%) and neophytadiene (4.8–4.4%), values referred to the non-polar and polar phase respectively. The enantioselective analysis revealed that (1S,5S)-(−)-α-pinene, (1S,5S)-(+)-β-pinene and (R)-(−)-α-phellandrene were enantiomerically pure, whereas germacrene D was present as a scalemic mixture. The essential oil of L. ovatus exhibited a minimum inhibitory concentration (MIC) of 250 µg/mL against Staphylococcus aureus and 500 µg/mL against Escherichia coli. Its antibacterial activity is likely associated with the presence of bioactive sesquiterpenes such as silphinene, δ-selinene, and spathulenol, which are known for their membrane-disruptive properties. Regarding its antioxidant potential, the observed moderate radical scavenging activity (SC50 = of 375.7 µg/mL) can be attributed to its complex mixture, particularly to oxygenated terpenoids like viridiflorol and spathulenol, which are recognized for their radical-neutralizing capacity. In the anti-inflammatory assay, the EO’s moderate potency (IC50 = 165.29 ± 4.75 μg/mL) is also consistent with the anti-inflammatory profile reported for several of its major constituents, including spathulenol and viridiflorol. While significantly lower than that of aspirin (28.85 ± 7.66 μg/mL), this bioactivity is considerable within the context of a plant extract. Overall, the antibacterial, antioxidant, and anti-inflammatory effects are consistent with the EO’s terpene-rich composition, particularly oxygenated sesquiterpenes, while the enantiomeric distribution of chiral monoterpenes may further modulate bioactivity; consequently, future studies should include enantioselective quantification, broader antioxidant assays (e.g., ABTS, FRAP, ORAC, CUPRAC), cytotoxicity at active concentrations, and mechanistic and in vivo validation.